Viewing nowNewmet 500 mg (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 201901971 · Approved 2019.04.01 · Insurance code 657806480
Treatment of type 2 diabetes mellitus
This drug is used in patients with type 2 diabetes who are not adequately controlled by diet and exercise, particularly in overweight adults and children and adolescents aged 10 years or older. In adults, it can be used alone or in combination with other oral hypoglycemic agents and insulin. Children and adolescents may also use it alone or in combination with insulin for effective blood sugar control. This helps to stabilize blood sugar levels and aids in diabetes treatment.
The dosage should be determined individually based on drug efficacy and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and determine the minimum dose needed for adequate glycemic control, treatment with this medicine must be started at a low dose. Administer 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. If the dose exceeds 2000mg, divide it into 3 doses daily and take with meals; the maximum daily dose is 2550mg. At the start of treatment and during dose adjustment, measure fasting blood glucose to assess response to treatment with this medicine and determine the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if a patient's blood glucose, previously controlled with diet alone, becomes temporarily uncontrolled, a short course of this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used in patients with stage 3a moderate renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other symptoms that may increase the risk of lactic acidosis, with the following dosage adjustments: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine must be discontinued immediately.
Children aged 10 years and older or adolescents during growth: The usual initial dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 doses.
This drug can cause severe lactic acidosis or hypoglycemia, so caution is required. It should not be administered to patients with moderate or severe renal impairment, or those in acute conditions such as dehydration, serious infections, or acute myocardial infarction. Patients with acute and unstable heart failure, those scheduled for tests using iodinated contrast agents, and patients with hypersensitivity to this drug or biguanide drugs should also avoid using it. Patients with type 1 diabetes or metabolic acidosis, severe infections, or trauma with systemic disorders should temporarily discontinue treatment, and administration should be paused for some time before and after surgery. Patients with liver dysfunction, excessive alcohol consumption, dehydration, gastrointestinal disturbances such as diarrhea or vomiting should avoid using this drug. The use of this drug is also not recommended for patients during pregnancy with placental insufficiency, preeclampsia, or risk of intrauterine growth retardation. Patients with lactose intolerance or genetic metabolic abnormalities should not take this drug. Caution should be exercised when there are irregular meals or insufficient food intake, vigorous exercise, or interactions with other drugs, as there is a risk of lactic acidosis and hypoglycemia. Gastrointestinal symptoms such as diarrhea, nausea, and vomiting are common but mostly temporary. Serious side effects such as lactic acidosis, anemia, blood cell reduction, liver dysfunction, hypoglycemia may occur rarely, so if symptoms appear, immediate consultation with a healthcare professional is required. Regularly monitor kidney function to prevent the accumulation of this drug and the risk of lactic acidosis, especially in elderly patients or those with reduced kidney function. Alcohol can affect the metabolism of this drug and increase the risk of lactic acidosis, so excessive drinking should be avoided during use. Continuously monitor blood sugar control and take appropriate measures if hypoglycemic symptoms occur. When used in conjunction with other hypoglycemic agents, the hypoglycemic effect can be enhanced or reduced, so it is essential to consult with a healthcare professional regarding concomitant medications. Blood sugar control is crucial during pregnancy, and since this drug crosses the placenta, patients planning to become pregnant or those who are pregnant should determine whether to take this drug after consulting with a healthcare professional. If breastfeeding, since this drug is excreted in breast milk, it is advisable to discuss whether to continue breastfeeding or discontinue medication with a healthcare professional. Elderly individuals commonly have reduced kidney function, so dose adjustment and monitoring of kidney function are essential. In cases of overdose, there is a risk of lactic acidosis, so if suspected, immediate medical attention should be sought for appropriate treatment such as blood dialysis. This drug aids in blood sugar control without causing weight gain, but caution is needed when used in children or adolescents. Finally, keep this drug in a safe place out of the reach of children and avoid transferring it to other containers.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container that is not exposed to air, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. This storage condition helps maintain the drug's efficacy for a longer period.
White, round film-coated tablet
300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.